Skip to content

EUmetriosis: Insights Into the Pathogenesis of Endometriosis

EUmetriosis: Insights Into the Pathogenesis of Endometriosis

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07000786
Acronym
EUmetriosis
Enrollment
60
Registered
2025-06-03
Start date
2025-05-12
Completion date
2029-12-31
Last updated
2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Brief summary

This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.

Interventions

PROCEDUREEndometrial biopsy or menstrual cup and blood sample

Enrolled patients will give their menstrual effluent either via a menstrual cup or via a pipelle biopsy. They will also undergo a blood draw.

Sponsors

Université Catholique de Louvain
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 56 Years
Healthy volunteers
Yes

Inclusion criteria

* Premenopausal * In spontaneous menstrual cycle (no hormonal treatments for the last 3 months) * Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy

Exclusion criteria

* HIV or Hepatitis positive * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Epigenetic analysisThroughout the entire study, approximately during 3,5 yearsHistone post-translational modifications

Countries

Belgium

Contacts

Primary ContactMarie-Madeleine Dolmans, MD, PhD
marie-madeleine.dolmans@uclouvain.be+32 (0)2 764 5287

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026